Case study: Speed meets excellence in global tuberculosis research
When a Phase 3 tuberculosis trial demanded aggressive timelines and complex multi-site coordination across the Philippines, Parexel delivered. We became the top-enrolling country globally, achieved ethics approvals 1.5 months faster than average, and got first patient enrolled in under 5 months.
See how strategic execution and innovation transformed complexity into competitive advantage.
Related Insights
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Case Study
Case study: Achieving a 7-week study start-up in a first in human autoimmune study
Jun 23, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Article
Case Study: Turning urgency into progress—Advancing new hope in AML
Jun 4, 2026
Blog
Three strategies to accelerate MASH trials in a competitive, rapidly shifting market
Apr 30, 2026
Playbook
Designing clinical development programs for radiopharmaceutical therapies
Mar 11, 2026
Blog
Slowing down to speed up: optimizing country and site selection in atopic dermatitis trials
Dec 30, 2025
Related Insights
Blog
Greater empathy, greater efficiency: How patient-first clinical development benefits all of us
Sep 10, 2026
CTB Blog
Modernizing data operations to enable today's Phase 1 trials
Jul 1, 2026
CTB Blog
In early phase trials, operations is where speed is won or lost
Jun 28, 2026
Article
Lessons from the Front Lines: Navigating the Operational Challenges of Next-Generation ADC Trials
Jun 26, 2026
Case Study
Case study: Achieving a 7-week study start-up in a first in human autoimmune study
Jun 23, 2026
Blog
A Deep Dive into the Genetic Therapies Bootcamp at the ACMG 2026 Annual Meeting
Jun 23, 2026
Blog
Hope Interrupted: Why Even Short Gaps in Rare Disease Treatment Matter More Than We Think
Jun 23, 2026
Article
Case Study: Turning urgency into progress—Advancing new hope in AML
Jun 4, 2026
Blog
Three strategies to accelerate MASH trials in a competitive, rapidly shifting market
Apr 30, 2026
Playbook
Designing clinical development programs for radiopharmaceutical therapies
Mar 11, 2026
Blog
Slowing down to speed up: optimizing country and site selection in atopic dermatitis trials
Dec 30, 2025